Cointime

Amira Pharmaceuticals

company

About

Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat

  • 11 - 50

Highlights

Total Funding Amount
$32M
Funding Rounds
3
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$25M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Feb 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Their discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$32M
Amira Pharmaceuticals has raised a total of $32M in funding over 2 rounds. Their latest funding was raised on Mar 23, 2007 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 23, 2007 Series B $25M 1 — — Detail
Nov 1, 2006 Series A $4M 1 — — Detail
Aug 10, 2005 Series A $3M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Amira Pharmaceuticals is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures — Series B
Cointime
เนื้อหา
บริษัท